Clinical trial
Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy
NCT00346853 · University of Utah, Other · Completed
Key facts
| NCT number | NCT00346853 |
|---|---|
| Title | Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy |
| Official title | Clinical Interventions Against Stargardt Macular Dystrophy: Phase 1 Pilot Study of 4-MP as an Inhibitor of Dark Adaptation |
| Lead sponsor | University of Utah, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Macular Dystrophy, Corneal |
| Intervention type | Drug, Other |
| Interventions | 4-Methylpyrazole, saline |
| Enrollment | 10 |
| Start date | Nov 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Jun 30, 2006 |
| Last update posted | Aug 5, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: